About us.

Emma has deep experience supporting organisations across the utilities, public and private sectors to deliver strategic projects and large-scale transformation programmes. At Inizio Advisory, Emma is responsible for driving all aspects of the Inizio Advisory strategy and bringing initiatives to life. Emma will also oversee the organisation's change programme. Prior to joining Inizio, Emma was a Director of EY's People Consulting business and also held the position of Chief of Staff for Ireland Consulting. Prior to joining EY, Emma also worked with Accenture Management Consulting.

Remco joined Putnam in 2000, becoming a Partner in 2010. Since then, he has served in various leadership positions, including COO and CFO, before being appointed to CEO in 2019 upon the acquisition of Putnam by UDG Healthcare. In addition to supporting the continued growth of the firm, Remco spends a portion of his time helping Putnam clients make better strategic decisions.

Jeff Dill is the CEO of Vynamic, a leading healthcare industry management consulting company helping innovative clients in the US, UK, and Europe achieve actionable strategy, operational intelligence, and healthy culture. With over 20 years of experience in consulting, Jeff started his career at Accenture and joined Vynamic in 2005 – inspired by their purpose: We Believe There Is A Better Way. Jeff is driven by his professional passion for ‘TACT’ - Transparency, Awareness, Clarity, and Trust - and has used this approach to clear communications to create a better experience for Vynamic team members and the clients they serve. Key elements of the healthy corporate culture Jeff leads have been featured on CNBC and The Wall Street Journal.

With a broad experience in the pharmaceutical industry spanning over more than 25 years, Dermot joined STEM as CEO in November 2021. As CEO, Dermot is responsible for driving growth and innovation within STEM. Prior to joining STEM Dermot spent 5 years at Novartis in the Clinical Development arena, first leading a major transformation in clinical data operations and then leading the broader clinical technology and innovation function. In this role, Dermot had responsibility for the support, oversight and evolution of Novartis’ end to end clinical technology platform and for driving digitization and innovation in the execution of clinical trials.

Serving as Advisory's Global President since September 2019, Colin Stanley has extensive experience in Senior Executive roles. He has been responsible for a business unit of 3,000 employees globally, providing strategic resourcing and functional services. He also held a number of roles during his 20-year career at ICON, including Chief Operating Officer of DOCS and Vice President of Clinical Operations in Asia.